The most common phenotypic changes observed in disseminated TAAD or AAA patients are a decrease in SMC protein expression (e.g. SM22-α) and an increase in inflammatory protein expression (e.g. matrix metalloproteinase-2 and MMP-9)32. The gene discussed is MMP2; the disease is triple-A syndrome.